For better website experience please use modern browsers like Chrome, FF or IE10+Ok
1. Overview: Clinical Research
Clinical Research at ACPN strives to promote and implement evidence-based clinical practice through well-designed research studies, using sound research methodology. This is in line with the mission of Department of Health (DOH) to promote world class research that improves health and quality of life of both citizens and residents, and in keeping with the vision of ACPN to be the leading regional neuroscience institute. This approach enables us to fulfill the vision of ACPN in providing the best evidence-based patient center care. Evidence-based practice helps in improving general quality of life through improved diagnosis and treatment, as well as reducing morbidity and mortality rates. Empirical evidence changes our approach to decision-making in clinical practice, while also giving us validity and credibility as one of the main healthcare providers in the UAE.
2. ACPN Institutional Review Board (IRB)
ACPN has a well-established Institutional Review Board, in compliance with the guidelines set by the International Council for Harmonization for Good Clinical Practice (ICH-GCP) and authorized by Department of Health (DOH) to run clinical trials and scientific research studies. The board is made up of both internal and external healthcare clinicians as well as academicians with expertise in Psychology, Psychiatry, Neurology, Neuropsychology, Pediatric Neurology, and Biomedical Engineering, among others The ACPN IRB serves to ensure ethical conduct of research in compliance with the aforementioned international policies and guidelines.
a. Academic and Scientific Research Institutions:
Khalifa University, Abu Dhabi
Zayed University, Abu Dhabi
New York University Abu Dhabi
Harvard Medical School Center for Global Health Delivery - Dubai
Imperial College London Diabetes Centre (ICLDC) - Abu Dhabi
b. Current Pharmaceutical supporters
4. Guidelines for Proposed Research Studies:
No restrictions on the type of research that can be conducted as long as:
Note on clinical trials:
Note: investigational medicinal product is one that has been given marketing authorization but is being investigated for uses other than what is indicated. Does not apply to Phase 1 trials.
5. Criteria for Research:
Proposed studies must meet the following criteria:
Benefit: Does the proposed study have clear benefits to the community in which it is conducted?
Effectiveness: Will the study be effective in achieving the desired goal?
Necessity: Is the study necessary to achieve the goal or is there an alternative that won’t infringe on a competing value?
Proportionality: Is the desired goal important enough to justify overriding another principle or value?
Least infringement: Is the study designed to minimize infringement on the values that conflict with it?
Transparency: Is the Primary Investigator prepared to publicly justify their decision?
6. Ethical Considerations:
Ethics regarding human subjects:
Respect for persons: respect autonomous choices; protect those lacking autonomy
Obtain informed consent from those capable of giving consent, proxy consent
Beneficence: do not harm; maximize benefits, minimize harms
Risk/benefit assessment is conducted, clear action if adverse effects arise
Justice: fairness in distribution; treat equals equally
Recruitment of subjects is fair, vulnerable populations not simply targeted out of convenience
7. Research Ethics Application: What to include
8. Application Submission Procedures:
9. Ongoing Clinical Research Studies:
10. Published Research Articles:
Sheikh Khalifa Medical City
Maudsley Health Abu Dhabi
Sheikh Khalifa Medical City
ACPN (IRB Coordinator)
For better web experience, please use the website in portrait mode